Literature DB >> 1634614

Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy.

M B Perryman1, Q T Yu, A J Marian, A Mares, G Czernuszewicz, J Ifegwu, R Hill, R Roberts.   

Abstract

We have determined that a missense mutation in exon 13 of the beta-myosin heavy chain (beta MHC) gene is expressed in the messenger RNA (mRNA) isolated from a right ventricular endomyocardial biopsy obtained from the proband of a family with hypertrophic cardiomyopathy. The mutation is the result of a substitution of an adenine for a guanine residue in one allele of the beta MHC gene and creates a second recognition site for the restriction endonuclease Ddel in exon 13. The mutation is inherited in a Mendelian fashion and co-segregates with hypertrophic cardiomyopathy in this family. Complementary DNAs synthesized from RNA isolated from the endomyocardial biopsy were cloned into a plasmid vector and sequenced to confirm the expression of both the normal and mutant allele in mRNA of myocardial tissue. This is the first report of the transcription of a mutant beta MHC gene allele into mRNA of the myocardium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634614      PMCID: PMC443092          DOI: 10.1172/JCI115848

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

3.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

Review 4.  Molecular genetics of myosin.

Authors:  C P Emerson; S I Bernstein
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance.

Authors:  B J Maron; W C Roberts
Journal:  Am Heart J       Date:  1981-07       Impact factor: 4.749

6.  Human cardiac myosin heavy chain genes and their linkage in the genome.

Authors:  L J Saez; K M Gianola; E M McNally; R Feghali; R Eddy; T B Shows; L A Leinwand
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

Review 7.  Causes of sudden death in competitive athletes.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

8.  Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy.

Authors:  N D Epstein; L Fananapazir; H J Lin; J Mulvihill; R White; J M Lalouel; R P Lifton; A W Nienhuis; M Leppert
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.

Authors:  R Matsuoka; M C Yoshida; N Kanda; M Kimura; H Ozasa; A Takao
Journal:  Am J Med Genet       Date:  1989-02

10.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

Authors:  B J Maron; P Spirito; Y Wesley; J Arce
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

View more
  14 in total

Review 1.  Molecular genetics of cardiomyopathies.

Authors:  G Shah; R Roberts
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.

Authors:  Y L Ko; J J Chen; T K Tang; J J Cheng; S Y Lin; Y C Liou; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  Molecular biology of heart disease.

Authors:  Robert Roberts
Journal:  World J Cardiol       Date:  2011-04-26

4.  Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.

Authors:  E Dausse; M Komajda; L Fetler; O Dubourg; C Dufour; L Carrier; C Wisnewsky; J Bercovici; C Hengstenberg; S al-Mahdawi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 5.  Multiple disease genes cause hypertrophic cardiomyopathy.

Authors:  H Watkins
Journal:  Br Heart J       Date:  1994-12

6.  A transgenic rabbit model for human hypertrophic cardiomyopathy.

Authors:  A J Marian; Y Wu; D S Lim; M McCluggage; K Youker; Q T Yu; R Brugada; F DeMayo; M Quinones; R Roberts
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 7.  Molecular basis of hypertrophic and dilated cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  Tex Heart Inst J       Date:  1994

8.  The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Authors:  S al-Mahdawi; S Chamberlain; L Chojnowska; E Michalak; P Nihoyannopoulos; M Ryan; B Kusnierczyk; J A French; D M Gilligan; J Cleland
Journal:  Br Heart J       Date:  1994-08

9.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.

Authors:  A J Marian; Q T Yu; A Mares; R Hill; R Roberts; M B Perryman
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.